Various approaches to transfection are utilized, ranging from electroporation and the use of nanoparticles to viral vector-based methods. The choice depends on both the nature of the project and the ...

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Non-Viral Transfection Method, Application ...

Dublin, June 23, 2020 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents and Systems Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. Over the last few years, the ...

During cell therapy development, some scientists are moving away from viral transfection and toward electroporation for introducing CRISPR systems and other nucleic acid payloads. As electroporation ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...

Despite the undeniable ability of viral vectors to deliver genetic payloads, and despite the incredible promise of this approach to treat a vast variety of diseases—including metabolic, cardiovascular ...

In part 1 of our interview with Leland Metheny, MD, he explained how a new triple-target chimeric antigen receptor (CAR) T-cell therapy works in multiple myeloma. In part 1 of our interview with ...

(MENAFN- GlobeNewsWire - Nasdaq) The non-viral transfection reagents market presents growth opportunities driven by the demand for cost-effective, low-immunogenicity alternatives to viral vectors, ...